Back to top

biofuels: Archive

Zacks Equity Research

Kinder Morgan (KMI) Boosts Green Portfolio Via Kinetrex Buyout

Kinder Morgan (KMI) expects the $310 million Kinetrex Energy acquisition to close in the third quarter of this year.

MMPPositive Net Change MURNegative Net Change KMIPositive Net Change CQPPositive Net Change

Zacks Equity Research

TotalEnergies (TTE), Veolia to Develop Microalgae for Biofuels

TotalEnergies (TTE) partners with Veolia to develop microalgae, which will ultimately assist the company in biofuel production. It strives to be a net-zero carbon emission company by 2050.

CVXNegative Net Change RDS.APositive Net Change SPWRPositive Net Change TTEPositive Net Change

Swayta Shah

5 Stocks With Upbeat Sales Growth Worth Betting on Right Now

Sales growth is crucial for the survival of any business. Let's check out CarMax (KMX), Crown Holdings (CCK), CenterPoint Energy (CNP), Nutrien (NTR) and Xylem (XYL) that are likely to record robust sales growth.

CNPNegative Net Change CCKNegative Net Change KMXPositive Net Change XYLPositive Net Change NTRNegative Net Change

Zacks Equity Research

Eni's (E) Versalis & Saipem to Produce Advanced Biofuel

The latest deal signed by Eni's (E) chemical company Versalis can play a huge role in the overall decarbonization program of the former.

ENegative Net Change PHXNo Net Change SAPMFNo Net Change EQNRNegative Net Change

Zacks Equity Research

How Aemetis (AMTX) Stock Stands Out in a Strong Industry

Aemetis (AMTX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

AMTXPositive Net Change

Zacks Equity Research

Zacks Industry Outlook Highlights: Moderna, Amgen, BioNTech, Repligen Corp and Ovid Therapeutics

Zacks Industry Outlook Highlights: Moderna, Amgen, BioNTech, Repligen Corp and Ovid Therapeutics

MRNAPositive Net Change OVIDPositive Net Change BNTXPositive Net Change

Zacks Equity Research

Alexion (ALXN) Tops Q1 Earnings, Merger With AstraZeneca On Track

Alexion (ALXN) tops earnings and sales in the first quarter of 2021. Its merger with AstraZeneca is expected to close in the third quarter.

ALXNPositive Net Change AZNPositive Net Change RGENPositive Net Change NBRVPositive Net Change

Zacks Equity Research

What Awaits Renewable Energy Group (REGI) in Q1 Earnings?

Renewable Energy's (REGI) Q1 results are expected to reflect rising biodiesel demand. However, higher feedstock costs might have hurt earnings.

CVXNegative Net Change AMRCPositive Net Change REGINegative Net Change DNOWPositive Net Change

Sweta Killa

5 Niche ETFs Dominating the Current Market Rally

We have highlighted five ETFs from different zones that were at the heart of the latest market rally over the past week and will likely to do so if the current trends prevail.

COPXNegative Net Change SGDJNegative Net Change LITPositive Net Change REMXNegative Net Change GERMNegative Net Change

Zacks Equity Research

What Awaits Renewable Energy Group (REGI) in Q4 Earnings?

Renewable Energy Group's (REGI) Q4 results are expected to reflect signs of improved biodiesel and renewable diesel demand.

ECNo Net Change REGINegative Net Change CEQPNegative Net Change FLMNPositive Net Change

Kevin Cook

Bear of the Day: CRISPR Therapeutics (CRSP)

Gene editors got a big boost recently from sickle cell potential and Cathie Wood's thematic investing

CRSPPositive Net Change EDITPositive Net Change ARKKPositive Net Change NTLAPositive Net Change ARKGPositive Net Change

Zacks Equity Research

Why Eastman Chemical (EMN) Might Surprise This Earnings Season

Eastman Chemical (EMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

EMNPositive Net Change

Tirthankar Chakraborty

5 ESG Stocks to Make the Most of the Bull Run in 2021

EV companies, alternative energy players and firms involved in hydrogen power generation are projected to gain in 2021. Notable among these are Tesla (TSLA) and FuelCell Energy (FCEL).

AESPositive Net Change GMPositive Net Change TSLAPositive Net Change FCELPositive Net Change ENPHNegative Net Change

Zacks Equity Research

Top Ranked Value Stocks to Buy for November 13th

Here are four stocks with buy rank and strong value characteristics for investors to consider today, November 13th

WMCPositive Net Change UNFINegative Net Change GPPPositive Net Change

Zacks Equity Research

Trevena (TRVN) to Report Q3 Earnings: What's in the Cards?

Trevena (TRVN) will provide updates on its newly launched drug and other pipeline products when it releases its third-quarter 2020 results.

ALKSNegative Net Change ALXNPositive Net Change ALNYNegative Net Change TRVNNegative Net Change

Daniel Laboe

Bear Of The Day: Nikola (NKLA)

Nikola (NKLA) bulls have gotten their face ripped clean off this week with the start-up's survival being put into question

SPCEPositive Net Change NKLAPositive Net Change DKNGNegative Net Change BPNegative Net Change

Zacks Equity Research

Pacific Ethanol's Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor Pacific Ethanol.

PEIXPositive Net Change

Sweta Jaiswal, FRM

Beat the Fed Minutes Blues With These ETF Areas

Let's look at some ETF areas that might continue being prudent investing options at a time when the Fed seems worried about the impact of the coronavirus outbreak on the U.S. economy.

IBBPositive Net Change XBIPositive Net Change ARKWPositive Net Change BOTZPositive Net Change ROBOPositive Net Change FDNPositive Net Change SKYYPositive Net Change ESGUPositive Net Change ROBTPositive Net Change CLOUPositive Net Change USSGPositive Net Change

Zacks Equity Research

Axsome's (AXSM) Earnings Beat in Q2, Pipeline Progresses

Axsome (AXSM) incurs a narrower loss in the second quarter of 2020. The company remains on track to submit the NDA for AXS-05 and AXS-07.

EBSPositive Net Change HZNPPositive Net Change PCRXPositive Net Change AXSMPositive Net Change

Zacks Equity Research

Should You Buy CF Industries (CF) Ahead of Earnings?

CF Industries (CF) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

CFNegative Net Change

Zacks Equity Research

Ultragenyx (RARE) Loss Narrows Y/Y & Revenues Beat Estimates

Ultragenyx (RARE) reports a narrower-than-expected loss in the second quarter of 2020 and beats sales estimates.

BMRNPositive Net Change EBSPositive Net Change RAREPositive Net Change APLTNegative Net Change

Zacks Equity Research

Blueprint Medicines' (BPMC) Q2 Earnings Miss, Revenues Beat

Blueprint Medicines (BPMC) posts a wider-than-expected loss but revenues beat estimates in the second quarter of 2020.

RHHBYPositive Net Change BMRNPositive Net Change EBSPositive Net Change BPMCPositive Net Change

Sweta Jaiswal, FRM

Late-Stage Coronavirus Vaccine Trials Begin: Biotech ETFs to Gain

Two major vaccine developers' entrance into the final stage trials is expected to boost investor optimism.

JNJNegative Net Change AZNPositive Net Change PFENegative Net Change MRNAPositive Net Change NVAXPositive Net Change IBBPositive Net Change XBIPositive Net Change BBHPositive Net Change FBTPositive Net Change ARKGPositive Net Change

Sweta Jaiswal, FRM

Biotech ETFs to Shine on Pfizer's Coronavirus Vaccine Progress

Two out of four of Pfizer's coronavirus vaccine candidates, BNT162b1 and BNT162b2, have been granted the 'fast track' designation by the FDA.

JNJNegative Net Change AZNPositive Net Change PFENegative Net Change MRNAPositive Net Change IBBPositive Net Change XBIPositive Net Change BBHPositive Net Change FBTPositive Net Change ARKGPositive Net Change

Sweta Jaiswal, FRM

Biotech ETFs to Gain as Coronavirus Vaccine Hopes Strengthen

As the coronavirus outbreak continues to aggravate, investors are eyeing developments in vaccine or treatments to combat the pandemic.

JNJNegative Net Change AZNPositive Net Change PFENegative Net Change MRNAPositive Net Change IBBPositive Net Change XBIPositive Net Change BBHPositive Net Change FBTPositive Net Change ARKGPositive Net Change